Local consolidative therapy for synchronous oligometastatic non-small cell lung cancer treated with first-line pembrolizumab: A retrospective observational study.

Thorac Cancer · 2022 · PMC8888157 · PMID 35060346

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

16 , 26 , 28 , 33 Consistent with their findings, our study also showed a trend toward improved outcomes in patients with high PD‐L1 expression.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.